Tigecycline : An investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms

Bacterial resistance to currently available antimicrobials is an increasing concern, particularly among various gram-positive organisms such as drug-resistant pneumococci, methicillin-resistant staphylococci, and drug-resistant enterococci. Tigecycline is an investigational glycylcycline antibiotic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical therapeutics 2005, Vol.27 (1), p.12-22
Hauptverfasser:	GARRISON, Mark W, NEUMILLER, Joshua J, SETTER, Stephen M
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Biological and medical sciences Clinical Trials, Phase II as Topic Drug Resistance, Bacterial Drugs, Investigational - adverse effects Drugs, Investigational - pharmacology Drugs, Investigational - therapeutic use Gram-Negative Bacteria - drug effects Gram-Positive Bacteria - drug effects Gram-Positive Bacterial Infections - drug therapy Humans Medical sciences Microbial Sensitivity Tests Minocycline - adverse effects Minocycline - analogs & derivatives Minocycline - pharmacology Minocycline - therapeutic use Pharmacology. Drug treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!